NUTRITION REVIEWS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2023-02-15 ms8000001908831640 来自山东省

请问返修需要审多久？

28 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2022-11-04 ms1000000845406468

审稿速度:3.0
偏重的研究方向：健康与疾病预防
经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？

41 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-29 ms6000000264964247

评审和期刊编辑要求我补实验，就一定要补么，不补行不行？

33 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-12-27 ms6000000264964247

对于审稿人好的意见也要回复么？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-11-07 ZhWe

审稿速度:3.0 | 投稿命中率:25.0
经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2021-02-11 ZhWe

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防
经验分享：值得一试的杂志

419 0

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2017-07-16 zheyang

还是5分多,虽然没有大变化,能稳定在些,也算是中上等

275 0

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2014-09-22 雪岱

相当高水准的杂志仍有一定涨幅空间

356 0

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2014-08-22 匿名用户

投稿命中率:5.0
经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作

370 0

[GetPortalCommentsPageByObjectIdResponse(id=2114686, encodeId=4d582114686bc, content=请问返修需要审多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16f8249299, createdName=ms8000001908831640, createdTime=Wed Feb 15 09:21:01 CST 2023, time=2023-02-15, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2098483, encodeId=5f662098483c7, content=审稿速度:3.0 偏重的研究方向：健康与疾病预防 经验分享：有人投综述的吗？审稿一般要多久？我的3个多月没动静了！能等到修改意见吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6965549776, createdName=ms1000000845406468, createdTime=Fri Nov 04 14:11:40 CST 2022, time=2022-11-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095843, encodeId=7be41095843f7, content=评审和期刊编辑要求我补实验，就一定要补么，不补行不行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095844, encodeId=0b46109584437, content=对于审稿人好的意见也要回复么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067713, encodeId=e5f7106e71346, content=审稿速度:3.0 | 投稿命中率:25.0 经验分享：大多数已发表的文章提示作者本人在本领域已有些建树 (reputation or track records, 例如已发表数篇原著)。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Sun Nov 07 02:40:41 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=924145, encodeId=adf592414559, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：临床医学;公共营养与个体营养;健康与疾病预防 经验分享：值得一试的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=419, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cbb21417611, createdName=ZhWe, createdTime=Thu Feb 11 06:30:39 CST 2021, time=2021-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544252, encodeId=71b4544252e1, content=还是5分多,虽然没有大变化,能稳定在些,也算是中上等, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=275, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zheyang, createdTime=Sun Jul 16 19:03:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506210, encodeId=1ab8506210b8, content=相当高水准的杂志仍有一定涨幅空间, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=356, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=雪岱, createdTime=Mon Sep 22 21:16:00 CST 2014, time=2014-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=505520, encodeId=7b32505520c6, content=投稿命中率:5.0 经验分享：年年看涨，英文要求较高，作者不应只综述他人工作，应有自己在该领域的原创工作, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=370, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Aug 22 23:25:00 CST 2014, time=2014-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=481368, encodeId=f70948136867, content=看涨哦，明年会不会再涨？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=412, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=medwu, createdTime=Wed Jun 29 15:51:00 CST 2011, time=2011-06-29, status=1, ipAttribution=)]

2011-06-29 medwu

看涨哦，明年会不会再涨？

412 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务